Lexaria Granted Strategically Important New U.S. Patent For DehydraTECH-Nicotine Including Oral Pouch Products
Portfolio Pulse from Happy Mohamed
Lexaria Bioscience Corp. has been granted a new patent by the US Patent and Trademark Office for its DehydraTECH-nicotine, including oral pouch products. The patent covers many types of nicotine for use in sublingual delivery formats. The oral nicotine pouch category is growing rapidly, with the global market expected to reach $11.91 billion in 2029. Meanwhile, at least 37 countries have banned the selling of e-cigarettes.
July 19, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Lexaria Bioscience Corp. has been granted a new patent for its DehydraTECH-nicotine. This could potentially boost the company's market position and revenue.
The granting of a new patent to Lexaria for its DehydraTECH-nicotine could potentially strengthen its market position and increase its revenue, especially considering the growing market for oral nicotine pouches.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
The new patent granted to Lexaria Bioscience Corp. for its DehydraTECH-nicotine could potentially increase the value of its warrants.
The granting of a new patent to Lexaria for its DehydraTECH-nicotine could potentially increase the value of its warrants, as it could strengthen the company's market position and increase its revenue.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100